Amylyx Pharmaceuticals (AMLX) Selling, General & Administrative (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) Selling, General & Administrative (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 304.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 588.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 184.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 18.47 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 318.50 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 381.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 264.59 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 109.67 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 57.53 Mn |
| 10 | Amylyx Pharmaceuticals | 1.51 Bn | 1.51 Bn | - | 16.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.17 Mn |
| Dec 31, 2025 | 15.39 Mn |
| Sep 30, 2025 | 16.17 Mn |
| Jun 30, 2025 | 15.64 Mn |
| Mar 31, 2025 | 15.68 Mn |
| Dec 31, 2024 | 17.10 Mn |
| Sep 30, 2024 | 17.83 Mn |
| Jun 30, 2024 | 21.65 Mn |
| Mar 31, 2024 | 57.76 Mn |
| Dec 31, 2023 | 52.24 Mn |
| Sep 30, 2023 | 48.72 Mn |
| Jun 30, 2023 | 43.39 Mn |
| Mar 31, 2023 | 44.01 Mn |
| Dec 31, 2022 | 40.84 Mn |
| Sep 30, 2022 | 29.94 Mn |
| Jun 30, 2022 | 29.99 Mn |
| Mar 31, 2022 | 26.35 Mn |
| Dec 31, 2021 | 14.92 Mn |
| Sep 30, 2021 | 10.35 Mn |
| Jun 30, 2021 | 7.66 Mn |